Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 57,561 | 50,583 | 47,680 | 50,832 | 45,849 |
| Cost of Goods | 17,872 | 20,831 | 19,386 | 14,989 | 12,964 |
| Gross Profit | 39,689 | 29,752 | 28,294 | 35,843 | 32,885 |
| Operating Expenses | 71,332 | 45,685 | 70,746 | 71,511 | 76,742 |
| Operating Income | -30,771 | -15,102 | -42,066 | -34,679 | -42,893 |
| Interest Expense | 16,817 | 7,462 | 12,443 | 22,461 | 13,022 |
| Other Income | 3,437 | 14,939 | 99 | -13,399 | 132 |
| Pre-tax Income | -44,151 | -7,625 | -54,410 | -70,539 | -55,783 |
| Income Tax | -14 | 245 | 0 | N/A | N/A |
| Net Income Continuous | -44,137 | -7,870 | -54,410 | -70,539 | -55,783 |
| Net Income | $-44,137 | $-7,870 | $-54,410 | $-70,539 | $-55,783 |
| EPS Basic Total Ops | -0.51 | -0.13 | -1.12 | -1.85 | -1.66 |
| EPS Basic Continuous Ops | -0.51 | -0.13 | -1.12 | -1.85 | -1.66 |
| EPS Diluted Total Ops | -0.51 | -0.13 | -1.12 | -1.85 | -1.66 |
| EPS Diluted Continuous Ops | -0.51 | -0.13 | -1.12 | -1.85 | -1.66 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.13 | -1.12 | -1.49 | -1.66 |
| EBITDA(a) | $-19,339 | $-11,785 | $-39,464 | $-27,984 | $-36,863 |